雷梅西维尔治疗对COVID-19患者的第八因子基因表达和血液学参数的影响
Ghazal Kakavand1, Somayeh Arabzadeh1, Sohameh Mohebbi1
1Department of Biology, Faculty of Basic Science, Ale Taha Institute of Higher Education, Tehran, Iran.
Microbial pathogenesis
|April 5, 2025
概括
COVID-19患者表现出与凝血相关的第八因子 (FVIII) 基因表达升高. 雷梅西维尔治疗没有改变FVIII水平,这表明它不会恶化COVID-19相关的凝血风险.
科学领域:
- 血液学 血液学 血液学
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- COVID-19与凝血障碍有关,包括高的第八因子 (FVIII) 水平,增加了血栓形成的风险.
- 了解抗病毒治疗期间的FVIII行为对于管理COVID-19并发症至关重要.
- 雷姆迪西维尔是一种用于治疗COVID-19的抗病毒药物,可能会影响各种血液因子.
研究的目的:
- 为了研究用Remdesivir治疗的COVID-19患者血液因子和FVIII基因表达的变化.
- 评估雷梅西维尔对FVIII表达的影响及其与其他血液参数的相关性.
主要方法:
- 实时PCR被用于分析30名COVID-19患者 (在Remdesivir治疗前后) 和20名健康对照的血液样本中的FVIII基因表达.
- 测量了血液中的生化参数,并在各组之间进行了比较.
- 进行了统计分析,以确定FVIII表达和临床参数之间的相关性.
主要成果:
- 与对照组相比,COVID-19患者表现出尿素,ALK,AST,WBC和CRP的水平升高.
- 雷梅西维尔治疗组显示FBS,尿素,ALK,AST,WBC,RDW,INR和K增加,而MCHC,红细胞和Ca水平下降.
- 在COVID-19患者中,FVIII基因表达上调,并且在雷姆迪西维尔治疗后仍然升高,在治疗前和治疗后的FVIII表达之间没有显著变化. 在患者和治疗组中观察到FVIII表达和RDW,尿素和P水平之间的负相关性.
结论:
- 在COVID-19患者中FVIII水平升高与疾病严重程度和高凝血性有关.
- 在COVID-19患者中,雷梅西维尔治疗似乎不会加剧FVIII水平或相关的凝血过程.
- 需要进一步的研究来充分阐明COVID-19,FVIII和抗病毒疗法之间的复杂相互作用.
相关概念视频
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
01:29Therapeutic Drug Monitoring: Affecting Factors
358
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
358
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
119
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
119
01:29Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
01:30Inhibitors of Viral Protein Synthesis
32
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32